Intuniv 1mg, 2mg, 3mg, 4mg prolonged-release tablets
*Company:
Takeda Products Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Chart 1 - Chart for ongoing monitoring
Risk Minimisation Materials
(Click to Download) Checklist 1 - Checklist for use prior to initiation of guanfacine
Risk Minimisation Materials
(Click to Download) Checklist 3 - Checklist for discontinuation of guanfacine including monitoring BP and pulse during downward titration
Risk Minimisation Materials
(Click to Download) HCP RMM Guide
Risk Minimisation Materials
(Click to Download) Checklist 2 - Checklist for ongoing monitoring and management of guanfacine
Risk Minimisation Materials